202 related articles for article (PubMed ID: 6147455)
1. Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy.
Atkinson S; Holcombe M; Kendall-Taylor P
Lancet; 1984 Aug; 2(8399):374-6. PubMed ID: 6147455
[TBL] [Abstract][Full Text] [Related]
2. A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity.
Kendall-Taylor P; Atkinson S; Holcombe M
Br Med J (Clin Res Ed); 1984 Apr; 288(6425):1183-6. PubMed ID: 6424781
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
[TBL] [Abstract][Full Text] [Related]
4. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
Molnár I; Balázs C
Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of Graves' ophthalmopathy.
Kendall-Taylor P
Clin Endocrinol Metab; 1985 May; 14(2):331-49. PubMed ID: 2415275
[TBL] [Abstract][Full Text] [Related]
6. The lack of specificity of ophthalmic immunoglobulins in Graves' disease.
Kadlubowski M; Irvine WJ; Rowland AC
J Clin Endocrinol Metab; 1986 Oct; 63(4):990-5. PubMed ID: 3755729
[TBL] [Abstract][Full Text] [Related]
7. [Muscle antigens recognized with autoantibodies in patients with Graves' ophthalmopathy].
Adler G
Endokrynol Pol; 1992; 43(1 Suppl):1-61. PubMed ID: 1345558
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
Morris JC; Hay ID; Nelson RE; Jiang NS
Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin class and subclass distribution of eye muscle and fibroblast antibodies in patients with thyroid-associated ophthalmopathy.
Tandon N; Yan SL; Arnold K; Metcalfe RA; Weetman AP
Clin Endocrinol (Oxf); 1994 May; 40(5):629-39. PubMed ID: 8013144
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
11. Thyroid-stimulating and eye muscle antibodies in Graves' disease and Graves' orbitopathy.
Kahaly G; Grübl M; Moncayo R; Schilling S; Weber P; Beyer J; Krause U
Dev Ophthalmol; 1989; 20():68-78. PubMed ID: 2574117
[No Abstract] [Full Text] [Related]
12. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
13. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
[TBL] [Abstract][Full Text] [Related]
14. Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.
McLachlan SM; Bahn R; Rapoport B
Autoimmunity; 1992; 14(2):143-8. PubMed ID: 1363894
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of immune damage in Graves' ophthalmopathy.
Hiromatsu Y; Wang PW; Wosu L; How J; Wall JR
Horm Res; 1987; 26(1-4):198-207. PubMed ID: 3596469
[TBL] [Abstract][Full Text] [Related]
17. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
18. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
Arnold K; Metcalfe R; Weetman AP
J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
[TBL] [Abstract][Full Text] [Related]
20. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
